Search results
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 4 days agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
Pyxis Oncology adds biopharma veteran to board By Investing.com
Investing.com· 11 hours agoPyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotechnology company developing therapies for...
SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell...
Digital Journal· 13 hours ago(OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering numerous treatment categories, announced ...
Woman awarded $260M from Johnson & Johnson following cancer diagnosis
WYMT Eastern Kentucky· 3 days agoA woman in Oregon was recently awarded $260 million in a lawsuit against pharmaceutical giant...
Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024
Benzinga· 4 days agoJINAN, China, June 6, 2024 /PRNewswire/ -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting convened from May 31 to June 4, 2024 in Chicago, USA, adopting a hybrid format. Among the presented works,
Ruvidar(TM) Enhances Efficacy of Cancer Drug
The Joplin Globe· 18 hours ago("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated ...
Catching cancer early lowers risk of mortality, but screening is the first step
Stacker via AOL· 6 days agoLast year, the initiative announced an additional $240 million investment to find new ways to...
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth | Investing.com PH
Investing.com· 7 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Rosty Raykov Sells 2,431 Shares of Stock
ETF DAILY NEWS· 7 days agoFennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 2,431 shares of the company’s stock in a transaction on Monday, June 3rd. Following the completion ...
MIRA reports promising Ketamir-2 study, eyes FDA submission By Investing.com
Investing.com· 11 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a company specializing in neurologic and neuropsychiatric...